Latest Press Releases
View all
TimeHeadline
2h agoThe Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet
Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H
2h agoKelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO
Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H
2h agoMax Power Mining Closes $25 Million Strategic Investment From Eric Sprott To Accelerate Commercial Evaluation at Lawson
Max Power Mining Corp
3h agoMach Travel Solutions Delivers Sustained FY26 Performance Despite Challenging Macro- Economic Environment; While Accelerating Transformation into an Integrated Travel Solutions Platform
Mach Conferences And Events Ltd.
4h agoVanta Announces Strategic Private Placement Financing to Advance U.S. Peptide Market Entry and Integrated Longevity and Consumer Health Sciences Platform
Vanta Holdings Inc.
Visionary Holdings Inc. logo

Visionary Holdings Inc.

About

0.33USD+0.00 +0.76%
Closed • Updated at 06:58 GMT+00:00
Market Cap$1.86M
Volume527.5K
Beta5.87
RSI58.15
Consumer ServicesOther Consumer Services

Visionary Holdings Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 4 2026
Visionary Holdings Inc. Announces Receipt of Nasdaq Delisting Determination Letter Related to Delinquent Listing Fees
Apr 10 2026
Visionary Holdings Inc. Announces Receipt of Nasdaq Minimum Bid Price Notification
Apr 7 2026
Visionary Holdings Inc. Announces Receipt of Nasdaq Continued Listing Deficiency Letter
Mar 31 2026
Visionary Holdings Signs Cooperation Agreement with Strategic Investment Partner for Proposed US$20 Million Investment in Qingdao Anti-Aging Project
Mar 26 2026
Visionary Holdings Inc. (NASDAQ: GV) Enters into Strategic Cooperation Agreement to Expand Distribution Capabilities for Its V-Series Anti-Aging Products in China

Community Chat

Ask AI

Try asking